PlainRecalls
FDA Drug Moderate Class II Terminated

Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2512-78, UPC 3 0378-2512-78 6.

Reported: July 15, 2015 Initiated: June 30, 2015 #D-1217-2015

Product Description

Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2512-78, UPC 3 0378-2512-78 6.

Reason for Recall

Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.

Details

Recalling Firm
Mylan Pharmaceuticals Inc
Units Affected
1068 bottles
Distribution
Nationwide
Location
Morgantown, PA

Frequently Asked Questions

What product was recalled?
Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-2512-78, UPC 3 0378-2512-78 6.. Recalled by Mylan Pharmaceuticals Inc. Units affected: 1068 bottles.
Why was this product recalled?
Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 15, 2015. Severity: Moderate. Recall number: D-1217-2015.